Your browser doesn't support javascript.
loading
Parenteral nutrition in clinical practice: International challenges and strategies.
Wischmeyer, Paul E; Klek, Stanislaw; Berger, Mette M; Berlana, David; Gray, Brenda; Ybarra, Joe; Ayers, Phil.
Afiliación
  • Wischmeyer PE; Department of Anesthesiology and Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Klek S; Surgical Oncology Clinic, The Maria Sklodowska-Curie National Cancer Institute, Krakow, Poland.
  • Berger MM; Service of Adult Intensive Care, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Berlana D; Pharmacy Service, Vall d'Hebron Barcelona Hospital Campus and Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
  • Gray B; Clinical Pharmacy Partners, Tampa, FL, USA.
  • Ybarra J; Steward Health Care, Dallas, TX, USA.
  • Ayers P; Clinical Pharmacy Services, Department of Pharmacy, Baptist Medical Center, Jackson, MS.
Am J Health Syst Pharm ; 81(Supplement_3): S89-S101, 2024 Jun 13.
Article en En | MEDLINE | ID: mdl-38869257
ABSTRACT

PURPOSE:

Parenteral nutrition (PN) is an established therapy when oral/enteral feeding is not sufficient or is contraindicated, but nevertheless PN remains a complex, high-alert medication that is susceptible to errors that may affect patient safety. Over time, considerable progress has been made to make PN practices safer. The purpose of this article is to address ongoing challenges to improve the PN use process from prescription to administration and monitoring, and to outline practical aspects fostering the safety, quality, and cost-effectiveness of PN, as discussed at the International Safety and Quality of PN Summit.

SUMMARY:

Opportunities to improve the PN use process in clinical practice include the promotion of inter-disciplinary communication, vigilant surveillance for complications, staff education to increase competency, and more consistent use of advanced technologies that allow automated safety checks throughout the PN process. Topics covered include considerations on PN formulations, including the value of intravenous lipid emulsions (ILEs), trends in compounding PN, the current and future role of market-authorized multi-chamber PN bags containing all 3 macronutrients (amino acids, glucose/dextrose, and ILE) in the United States and in Europe, and strategies to cope with the increasing global problem of PN product shortages.

CONCLUSION:

This review outlines potential strategies to use in clinical practice to overcome ongoing challenges throughout the PN use process, and ultimately promote PN patient safety.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Nutrición Parenteral Límite: Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: Am J Health Syst Pharm Asunto de la revista: FARMACIA / HOSPITAIS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Nutrición Parenteral Límite: Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: Am J Health Syst Pharm Asunto de la revista: FARMACIA / HOSPITAIS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos